Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
Xuqi Sun,1– 3,* Dandan Hu,1,2,* Zhoutian Yang,1,2 Zheng Liu,3,4 Juncheng Wang,1,2 Jinbin Chen,1,2 Li Xu,1,2 Zhongguo Zhou,1,2 Minshan Chen,1,2 Yaojun Zhang1,2 1Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer...
Main Authors: | Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/baseline-hbv-loads-do-not-affect-the-prognosis-of-patients-with-hepato-peer-reviewed-article-JHC |
Similar Items
-
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
by: Hu Z, et al.
Published: (2022-04-01) -
Hepatitis B viral load and risk of HBV-related liver disease: from East to West?
by: Soeradj Harkisoen, M.D., et al.
Published: (2012-03-01) -
Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
by: Pierre Nahon, et al.
Published: (2021-01-01) -
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
by: Suresh Gopi Kalathil, et al.
Published: (2021-05-01) -
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
by: Robert L. Kruse, et al.
Published: (2017-12-01)